ArticleOrphanet journal of rare diseases2025
The Danish Turner Syndrome Cryopreservation study: PROTOCOL for a prospective cohort Study on reproductive outcomes after ovarian tissue cryopreservation in girls with Turner syndrome.
Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05740579 (The Danish TURNER Cryopreservation Study), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Danish TURNER Cryopreservation Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundTurner syndrome (TS) is a chromosomal disorder caused by complete or partial loss of one X chromosome, resulting in a high risk of premature ovarian insufficiency (POI) and infertility. While the underlying mechanisms are not fully understood, oocyte loss is known to begin in fetal life and continue throughout childhood, often leading to ovarian failure before the onset of puberty. Ovarian tissue cryopreservation (OTC) offers a potential method to preserve fertility in girls with TS, but the procedure remains experimental in this group. To date, only three cases of autotransplantation have been reported, and no live births have occurred in women with TS. Moreover, predictors of residual ovarian function and eligibility for OTC are poorly defined, and the long-term effects of unilateral oophorectomy in girls with already limited ovarian reserve are unknown.
objectiveTo investigate long-term reproductive outcomes following OTC in girls with TS.
methodsThe Danish Turner Syndrome Cryopreservation Study is a nationwide, prospective cohort study with long-term follow-up, combining observational and interventional elements. Girls with TS aged 2–17 years are invited to participate. As ovarian reserve is depleted before adulthood in most girls with TS, all participants undergo ovarian function assessment to evaluate the likelihood of remaining viable follicles. If follicles are deemed present, unilateral OTC may be offered. The primary outcome is the number of pregnancies, miscarriages, and live births following autotransplantation of cryopreserved and thawed ovarian tissue in adulthood. Secondary objectives include identifying early predictors of POI, assessing the impact of oophorectomy on ovarian function and pubertal progression, and exploring molecular mechanisms of ovarian dysgenesis through genetic and epigenetic analyses of ovarian and peripheral tissues. Recruitment began in January 2024 and is ongoing at three university hospitals across Denmark. Follow-up is expected to continue until 2050.
conclusionThis study addresses a critical gap in fertility preservation for girls with TS by evaluating the feasibility and long-term outcomes of OTC. The findings will improve understanding of POI progression, refine selection criteria for OTC, and support evidence-based counselling for girls with TS and their families.
trial registrationClinicalTrials.gov, NCT05740579. Registered 13 February 2023. https//clinicaltrials.gov/study/NCT05740579.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.